ES397573A1 - Biologically active imidazoles - Google Patents
Biologically active imidazolesInfo
- Publication number
- ES397573A1 ES397573A1 ES397573A ES397573A ES397573A1 ES 397573 A1 ES397573 A1 ES 397573A1 ES 397573 A ES397573 A ES 397573A ES 397573 A ES397573 A ES 397573A ES 397573 A1 ES397573 A1 ES 397573A1
- Authority
- ES
- Spain
- Prior art keywords
- group
- optionally substituted
- groups
- hydroxyl
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/52—Nitrogen atoms not forming part of a nitro radical with hetero atoms directly attached to said nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A process for the preparation of new substituted imidazoles of general formula (VI) ** formula ** or a tautomeric or structural isomer thereof as defined above, where R1 is a carbocyclic or heterocyclic aromatic group, optionally substituted with one or more atoms optionally substituted halogen, hydroxyl, amino, thiol, sulfonic, or carboxylic groups or cyano, nitro, acyl, alkyl, aryl, or haloalkyl groups; R2 is an amino or hydroxyl group or an alkoxy, aryloxy or aralkoxy group optionally substituted with one or more halogen atoms or optionally substituted hydroxyl or tertiary amino groups, R4 is a hydrogen atom or a methyl group, R3 is an N = group N-NR5R6, where R5 is a beta-halogenated methyl or ethyl group and R6 is a hydrogen atom or a hydrocarbon group optionally substituted with a halogen atom or an optionally substituted tertiary amino or hydroxyl group and addition salts with acids, solvates or addition salts with solvated acids thereof, the process of which comprises the step of reacting the compound of the general formula ** formula ** where R''4 is a negative casing or a methyl group, with a compound of the general formula HNR5R6, whereupon optionally, if desired, replacing or modifying groups R1, R2 and/or R4 to provide other groups, R1, R2 and/or R4 by known method. (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5838570A GB1373346A (en) | 1970-12-09 | 1970-12-09 | Biologically active imidazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES397573A1 true ES397573A1 (en) | 1975-10-01 |
Family
ID=10481482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES397573A Expired ES397573A1 (en) | 1970-12-09 | 1971-12-01 | Biologically active imidazoles |
Country Status (13)
| Country | Link |
|---|---|
| AT (1) | AT310740B (en) |
| BE (1) | BE776422A (en) |
| CA (1) | CA979428A (en) |
| DE (1) | DE2161209A1 (en) |
| ES (1) | ES397573A1 (en) |
| FR (1) | FR2117939B1 (en) |
| GB (1) | GB1373346A (en) |
| HU (1) | HU163484B (en) |
| IE (1) | IE35817B1 (en) |
| IL (1) | IL38174A0 (en) |
| NL (1) | NL7116331A (en) |
| SE (1) | SE7412430L (en) |
| ZA (1) | ZA717873B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3084804A1 (en) * | 2017-12-06 | 2019-06-13 | Yale University | Prodrugs activated by reduction in the cytosol |
-
1970
- 1970-12-09 GB GB5838570A patent/GB1373346A/en not_active Expired
-
1971
- 1971-11-17 IE IE1448/71A patent/IE35817B1/en unknown
- 1971-11-18 IL IL38174A patent/IL38174A0/en unknown
- 1971-11-23 ZA ZA717873A patent/ZA717873B/en unknown
- 1971-11-26 NL NL7116331A patent/NL7116331A/xx unknown
- 1971-11-26 CA CA128,705A patent/CA979428A/en not_active Expired
- 1971-12-01 ES ES397573A patent/ES397573A1/en not_active Expired
- 1971-12-03 AT AT1042171A patent/AT310740B/en not_active IP Right Cessation
- 1971-12-08 FR FR7144014A patent/FR2117939B1/fr not_active Expired
- 1971-12-08 BE BE776422A patent/BE776422A/en unknown
- 1971-12-09 DE DE19712161209 patent/DE2161209A1/en active Pending
- 1971-12-09 HU HUBE1108A patent/HU163484B/hu unknown
-
1974
- 1974-10-02 SE SE7412430A patent/SE7412430L/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2117939B1 (en) | 1975-06-13 |
| NL7116331A (en) | 1972-06-13 |
| ZA717873B (en) | 1972-08-30 |
| DE2161209A1 (en) | 1972-06-22 |
| IE35817L (en) | 1972-06-09 |
| BE776422A (en) | 1972-06-08 |
| AU3658871A (en) | 1973-06-14 |
| IE35817B1 (en) | 1976-05-26 |
| CA979428A (en) | 1975-12-09 |
| FR2117939A1 (en) | 1972-07-28 |
| HU163484B (en) | 1973-09-27 |
| IL38174A0 (en) | 1972-01-27 |
| GB1373346A (en) | 1974-11-13 |
| AT310740B (en) | 1973-10-10 |
| SE7412430L (en) | 1974-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES393496A1 (en) | Cerivatives of 2-pyrrolidinone | |
| SE7712630L (en) | PROCEDURE FOR THE PREPARATION OF O-ALKYLATED HYDROXYLAMINES | |
| ES462422A1 (en) | Sulfonylglycolic anilide fungicides | |
| SE7600954L (en) | TETRAHYDROISOKINOLINE DERIVATIVES AND PROCEDURES FOR THE MANUFACTURE | |
| ES410190A1 (en) | Novel metallized heterocyclic derivatives | |
| ES397573A1 (en) | Biologically active imidazoles | |
| ES404744A1 (en) | Cephalosporin derivatives | |
| SE7612685L (en) | PROCEDURE FOR PREPARING NEW IMIDAZOLE COMPOUNDS | |
| ES395766A1 (en) | Procedure for the obtaining of derivatives of hidantoin. (Machine-translation by Google Translate, not legally binding) | |
| ES328052A1 (en) | Procedure for the preparation of thiophosphates with antiparastic effect. (Machine-translation by Google Translate, not legally binding) | |
| ES451292A1 (en) | A procedure for the preparation of tienotiacin derivatives. (Machine-translation by Google Translate, not legally binding) | |
| ES400414A1 (en) | Procedure for the preparation of N-substituted piperidine derivatives and their use as stabilizers. (Machine-translation by Google Translate, not legally binding) | |
| ES420766A1 (en) | Alpha-pyrone derivatives and the preparation and uses thereof | |
| ES437041A1 (en) | A procedure for preparing 1-ftalazone derivatives. (Machine-translation by Google Translate, not legally binding) | |
| ES398973A1 (en) | N-derivatives of 4-amino-4-desoxy-rifamycin sv and preparation | |
| ES425868A1 (en) | Preparation of carbamates | |
| ES391118A1 (en) | Novel glucuronic acid derivatives and process for the preparation thereof | |
| ES432535A1 (en) | A procedure for the preparation of benzodiazepinas-1,4. (Machine-translation by Google Translate, not legally binding) | |
| ES427387A1 (en) | A procedure for the preparation of colorants. (Machine-translation by Google Translate, not legally binding) | |
| ES392665A1 (en) | Novel process for preparing i-substituted benzodiazepine derivatives | |
| ES439939A1 (en) | Procedure for the preparation of new derivatives of isoxazolone. (Machine-translation by Google Translate, not legally binding) | |
| ES362824A1 (en) | Procedure for obtaining antiulcerosous compounds. (Machine-translation by Google Translate, not legally binding) | |
| ES389920A1 (en) | Processes for producing 2-benzoylalkylbenzomorphan derivatives and their salts | |
| ES402255A1 (en) | 1,4,2-dioxazine derivatives and preparation | |
| ES435935A1 (en) | A procedure for the preparation of benzodiacepine derivatives. (Machine-translation by Google Translate, not legally binding) |